The phenotype of myeloid neoplasms may depend on the intensity of signaling on specific downstream targets in the JAK-STAT signaling pathway, which is related to the number of JAK2 V617F copies and the presence of additional gene mutations affecting RNA splicing genes or epigenetic regulators [7]. This evidence concerns the gene JAK2 and myeloid neoplasm.